A precise diagnosis of multiple sclerosis would be of great importance for research and clinical management, for at present it is a matter of probability and exclusion. Recently Field et al' claimed to have found a diagnostic test for multiple sclerosis which was said to be valid in each phase of the disease and extremely specific. In this test the electrophoretic mobility of erythrocytes of patients with multiple sclerosis (MS) is inhibited in the presence of linoleic acid.
The test is based on results which indicate an anomaly of fatty acid metabolism producing changes both in myelin composition and in the lipid structure of other cells, for instance red blood cells. [2] [3] [4] [5] Reported results on the value of this so-called E-UFA (erythrocyte-unsaturated fatty acid) test have been controversial. 6-9 We therefore examined this particular test and the followino paper describes our experiences and results.
Material and method:
Fresh red blood cells (RBC) were prepared from 20 MS patients in different stages of the disease. Only those patients who could be judged as definite, using the criteria of McAlpine, were selected.'0 Three apparently healthy persons and 19 patients with other neurological disorders (OND) (cerebrovascular told us they did not use a diet containing a high quantity of polyunsaturated fatty acids.
The method used was essentially the same as described by Field.' Red blood cells were prepared by defibrination of 15 ml of fresh blood with glass beads under sterile conditions. The further procedure was carried out in tubes and pipettes highly purified for one day in n-HCI and bidistilled water, but not sterilised; sterilisation did not prove to be of any importance in preliminary experiments. The red cells were washed three times in sterile 0-9% saline and then once in Hanks Medium 199 and centrifuged at 400 g after each step. Finally they were suspended in this medium at a concentration of 2-8 x 107 cells/ml and processed immediately. The specific resistance of our medium was determined in the conductolyser and had a value of about 70 (+2) Ql per cm. The determinations were carried out blindly, that is the examiner did not know whose blood he was processing. After determining the mobility of the erythrocytes without linoleic acid, a consecutive redetermination was done by adding 20 gl (equivalent to 0-16 g/l) of highly purified linoleic acid to the erythrocyte suspension. We chose this concentration on the basis of a suggestion made by Field, who told us that the higher concentration would bring better results. The temperature of the measuring chamber remained constant at 25'C.
In the second half of the experiments, detergents (Tween 80, Triton) were added to the suspension in order to improve the solubility of linoleic acid. In those cases determinations were performed (or the attempt was made to do so) with and without detergents.
Results

I MS Patients
The values of each patient blood either with or without linoleic acid (LA) are shown in table 1. The addition of LA led to rather irregularpositive or negative-deviations (p not significant using the Wilcoxon test). The range was from -9-94 to +6-78% with a mean value of -0-92%.
Most determinations were performed two or 
